| scholarly article | Q13442814 |
| P50 | author | Rodrigo Aguayo-Ortiz | Q64683190 |
| P2093 | author name string | Joseph M Autry | |
| Eli Fernández-de Gortari | |||
| L Michel Espinoza-Fonseca | |||
| P2860 | cites work | Structure and orientation of sarcolipin in lipid environments | Q24292113 |
| Effects of phospholamban transmembrane mutants on the calcium affinity, maximal activity, and cooperativity of the sarcoplasmic reticulum calcium pump | Q24309928 | ||
| Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome | Q24337593 | ||
| Sarcolipin uncouples hydrolysis of ATP from accumulation of Ca2+ by the Ca2+-ATPase of skeletal-muscle sarcoplasmic reticulum | Q24533577 | ||
| Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban | Q24678050 | ||
| Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution | Q27625023 | ||
| The Structural Basis for Phospholamban Inhibition of the Calcium Pump in Sarcoplasmic Reticulum | Q27679847 | ||
| SERCA mutant E309Q binds two Ca2+ions but adopts a catalytically incompetent conformation | Q27680675 | ||
| Crystal structures of the calcium pump and sarcolipin in the Mg2+-bound E1 state | Q27684107 | ||
| The sarcolipin-bound calcium pump stabilizes calcium sites exposed to the cytoplasm | Q27684110 | ||
| Scalable molecular dynamics with NAMD | Q27860718 | ||
| Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types | Q29616710 | ||
| Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca(2+)-ATPase | Q30464872 | ||
| Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals. | Q30540446 | ||
| Phosphorylation-induced structural changes in smooth muscle myosin regulatory light chain | Q33929417 | ||
| Atomic-level mechanisms for phospholamban regulation of the calcium pump. | Q35333572 | ||
| Sarcolipin Is a Key Determinant of the Basal Metabolic Rate, and Its Overexpression Enhances Energy Expenditure and Resistance against Diet-induced Obesity. | Q35536274 | ||
| The N Terminus of Sarcolipin Plays an Important Role in Uncoupling Sarco-endoplasmic Reticulum Ca2+-ATPase (SERCA) ATP Hydrolysis from Ca2+ Transport | Q35662355 | ||
| Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles | Q36546184 | ||
| Sarco(endo)plasmic reticulum calcium ATPase (SERCA) inhibition by sarcolipin is encoded in its luminal tail | Q36708601 | ||
| Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase | Q37232028 | ||
| Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology | Q37252432 | ||
| Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban | Q37255989 | ||
| The sarcoplasmic Ca2+-ATPase: design of a perfect chemi-osmotic pump | Q37784543 | ||
| Thermodynamic and structural basis of phosphorylation-induced disorder-to-order transition in the regulatory light chain of smooth muscle myosin. | Q40709998 | ||
| Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP. | Q40880128 | ||
| Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum | Q41035597 | ||
| Increased Reliance on Muscle-based Thermogenesis upon Acute Minimization of Brown Adipose Tissue Function | Q41045820 | ||
| Phospholamban domain I/cytochrome b5 transmembrane sequence chimeras do not inhibit SERCA2a | Q41047973 | ||
| Phospholamban inhibitory function is activated by depolymerization | Q41105112 | ||
| Phospholamban regulates the Ca2+-ATPase through intramembrane interactions | Q41168796 | ||
| Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. | Q41768288 | ||
| Sarcolipin and phospholamban inhibit the calcium pump by populating a similar metal ion-free intermediate state. | Q41834129 | ||
| Effects of pseudophosphorylation mutants on the structural dynamics of smooth muscle myosin regulatory light chain. | Q42675569 | ||
| Sarcolipin Promotes Uncoupling of the SERCA Ca2+ Pump by Inducing a Structural Rearrangement in the Energy-Transduction Domain | Q42943217 | ||
| Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes | Q43645352 | ||
| On the role of electrostatic interactions in the design of protein-protein interfaces | Q44021056 | ||
| Ablation of sarcolipin decreases the energy requirements for Ca2+ transport by sarco(endo)plasmic reticulum Ca2+-ATPases in resting skeletal muscle | Q44123306 | ||
| Ca2+ occlusion and gating function of Glu309 in the ADP-fluoroaluminate analog of the Ca2+-ATPase phosphoenzyme intermediate | Q44901190 | ||
| Protein-phospholipid interplay revealed with crystals of a calcium pump. | Q51022558 | ||
| Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. | Q51550011 | ||
| The presence of sarcolipin results in increased heat production by Ca(2+)-ATPase. | Q51932184 | ||
| Residue-residue potentials with a favorable contact pair term and an unfavorable high packing density term, for simulation and threading. | Q52310162 | ||
| A solid-state NMR study of the phospholamban transmembrane domain: local structure and interactions with Ca(2+)-ATPase. | Q52541181 | ||
| Valid molecular dynamics simulations of human hemoglobin require a surprisingly large box size | Q56797790 | ||
| PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions | Q57129760 | ||
| Regulatory Role of Phospholamban in the Efficiency of Cardiac Sarcoplasmic Reticulum Ca2+Transport† | Q62083031 | ||
| Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. Effects of synthetic phospholamban peptides on Ca2+ pump ATPase | Q68052326 | ||
| Residues 2-25 of phospholamban are insufficient to inhibit Ca2+ transport ATPase of cardiac sarcoplasmic reticulum | Q70745212 | ||
| Defining the molecular components of calcium transport regulation in a reconstituted membrane system | Q73267227 | ||
| Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase | Q74290669 | ||
| Microsecond Molecular Simulations Reveal a Transient Proton Pathway in the Calcium Pump | Q85264779 | ||
| Correlation Coefficients: Appropriate Use and Interpretation | Q87882653 | ||
| Redistribution of SERCA calcium pump conformers during intracellular calcium signaling | Q88683670 | ||
| Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca2+-ATPase at saturating Ca2+ conditions | Q89206165 | ||
| Phospholamban deficiency does not alter skeletal muscle SERCA pumping efficiency or predispose mice to diet-induced obesity | Q90849426 | ||
| The Phospholamban Pentamer Alters Function of the Sarcoplasmic Reticulum Calcium Pump SERCA | Q91321387 | ||
| Thermodynamics of Cation Binding to the Sarcoendoplasmic Reticulum Calcium ATPase Pump and Impacts on Enzyme Function | Q91929376 | ||
| Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers | Q92869535 | ||
| P304 | page(s) | 705-713 | |
| P577 | publication date | 2020-02-28 | |
| P1433 | published in | Computational and Structural Biotechnology Journal | Q19865804 |
| P1476 | title | A hallmark of phospholamban functional divergence is located in the N-terminal phosphorylation domain | |
| P478 | volume | 18 |
Search more.